-
Mashup Score: 8How AI Might Streamline Clinical Trial Screening - 1 month(s) ago
This Medical News article is an interview with Alexander J. Blood, MD, MSc, about the potential for AI to help screen patients for clinical trials, and why more efficient study enrollment could ultimately mean better real-world outcomes for patients.
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 6How AI Might Streamline Clinical Trial Screening - 1 month(s) ago
This Medical News article is an interview with Alexander J. Blood, MD, MSc, about the potential for AI to help screen patients for clinical trials, and why more efficient study enrollment could ultimately mean better real-world outcomes for patients.
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet-
RT @AJBloodMD: https://t.co/MmlUlRiv0v Excited to share my recent interview with @JAMA_current , discussing #AI in clinical trials. These…
-
-
Mashup Score: 3LinkedIn - 2 month(s) ago
This link will take you to a page that’s not on LinkedIn
Source: lnkd.inCategories: General Medicine News, CardiologistsTweet-
RT @AJBloodMD: Excited to share our group's publication out today - the MAPS-LLM trial. https://t.co/S8Uk2eswUY. The study, now out in JAMA…
-
-
Mashup Score: 10
Critical care cardiology refers to the practice focus of and subspecialty training for the comprehensive management of life-threatening cardiovascular diseases and comorbid conditions that require advanced critical care in an intensive care unit. The development of coronary care units is often credited for a dramatic decline in mortality rates after acute myocardial infarction throughout the 1960s. As the underlying patient population became progressively sicker, changes in organizational structure, staffing, care delivery, and training paradigms lagged. The coronary care unit gradually evolved from a focus on rapid resuscitation from ventricular arrhythmias in acute myocardial infarction into a comprehensive cardiac intensive care unit designed to care for the sickest patients with cardiovascular disease. Over the past decade, the cardiac intensive care unit has continued to transform with an aging population, increased clinical acuity, burgeoning cardiac and noncardiac comorbidities,
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
RT @SarasVallabhMD: Read our @AHAScience Statement on #CriticalCareCardiology in @CircAHA - https://t.co/WL9hTXSlb4. This builds on the fou…
-
-
Mashup Score: 87Survivorship After Cardiogenic Shock | Circulation - 3 month(s) ago
Advances in critical care therapies for patients with cardiogenic shock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to hospital discharge, ranging from 60% to 70%. After their index hospitalization, however, survivors of CS may continue to face cardiac as well as extracardiac sequelae of these therapies and complications for years to come. Most studies in CS have focused primarily on survival, with limited data on long-term recovery measures among survivors. In other forms of critical illness, research indicates that many intensive care unit survivors experience impairments in multiple domains, such as cognitive function, physical ability, and mental health. These impairments, collectively referred to as Post–Intensive Care Syndrome, in turn impact survivors’ quality of life and future prognosis. This review identifies unique aspects of CS–related survivorship, highlights lessons learned from other forms of c
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
For #Shock survivors, hospitalization is only the beginning. How should we take care of these patients longitudinally? Grateful to co-author this review @CircAHA led by @UTSWCardfellow #EricHallMD @MaryjaneFarrMD @WesElyMD & more! @ISHVnews @InovaHealth https://t.co/F72tT8oEcO https://t.co/bpvdkWcbAo
-
-
Mashup Score: 11How Steep is Your Slide? I Really Mean to Learn - 7 month(s) ago
‘Cause we’re living in a world of fools, breaking us down, when they all should let us be…Bee Gees. “How Deep is your Love.’ September, 1977.
Source: onlinejcf.comCategories: General Medicine News, CardiologistsTweet-
@robmentz @JCardFail @NavinKapur4 @manreetkanwar @JHMontfort10 @MGuglin @rachkataria @GavHick @MaryjaneFarrMD @BurkhoffMd @dranulala @DrMarthaGulati @AndrewJSauer @noshreza @HFSA Appreciate the excellent editorial by @BalimSenmanMD @JasonKatzMD et al Great title and thanks for placing our work in context! 🙏🏾 Check it out: How Steep is Your Slide in your CS patients? 🛝 🤔 👀 https://t.co/VA6bZyXieQ
-
-
Mashup Score: 4Voluntary Reporting of Guideline-Directed Medical Therapy Use Rates in the Public Domain: A Challenge to the Heart Failure Community - 8 month(s) ago
Achieving target or maximally tolerated doses of Guideline Directed Medical Therapy (GDMT) is associated with decreased morbidity and mortality rates in patients with heart failure and reduced ejection fraction (HFrEF).1 However, in a contemporary cohort of outpatients with HFrEF, the percentage of patients achieving target dosages of GDMT was woefully low, with < 1% of patients achieving target dosages of 3 foundational components of GDMT: (ACE [angiotensin converting enzyme inhibitor], ARB [angiotensin receptor blocker], or ARNI [angiotensin receptor/neprilysin inhibitor]); beta-blocker; and MRA [mineralocorticoid receptor antagonist] at 1-year follow-up.
Source: onlinejcf.comCategories: General Medicine News, CardiologistsTweet-
RT @JTThibs: As per our previous challenge to the HF community https://t.co/OI6yhHnd9O, we continue to publicly share our #GDMT rates for p…
-
-
Mashup Score: 4Professionals In Training (PIT) Lounge | HFSA - 8 month(s) ago
The Professionals In Training (PIT) Lounge is THE SPOT at ASM for all professionals who are in the early stage of their career! Complete with programming centered on career development and professional growth, the PIT Lounge can’t be missed. Make a “PIT stop” here to learn, network, and recharge your battery with refreshments. 7:45 AM – 8:45 AM Panel Session: Careers in Heart Failure, moderated by Dr. Sarah Chuzi Learn from a diverse panel about career options including Physician Scientist, VA, Industry,
Source: hfsa.orgCategories: General Medicine News, CardiologistsTweet-
RT @SpencerCarter55: https://t.co/ig472KIV2G Link above for the exciting PIT lounge sessions exploring job types, leadership, how to be a…
-
-
Mashup Score: 4Voluntary Reporting of Guideline-Directed Medical Therapy Use Rates in the Public Domain: A Challenge to the Heart Failure Community - 8 month(s) ago
Achieving target or maximally tolerated doses of Guideline Directed Medical Therapy (GDMT) is associated with decreased morbidity and mortality rates in patients with heart failure and reduced ejection fraction (HFrEF).1 However, in a contemporary cohort of outpatients with HFrEF, the percentage of patients achieving target dosages of GDMT was woefully low, with < 1% of patients achieving target dosages of 3 foundational components of GDMT: (ACE [angiotensin converting enzyme inhibitor], ARB [angiotensin receptor blocker], or ARNI [angiotensin receptor/neprilysin inhibitor]); beta-blocker; and MRA [mineralocorticoid receptor antagonist] at 1-year follow-up.
Source: onlinejcf.comCategories: General Medicine News, CardiologistsTweet-
RT @JTThibs: As per our previous challenge to the HF community https://t.co/OI6yhHnd9O, we continue to publicly share our #GDMT rates for p…
-
-
Mashup Score: 49linkedin - 9 month(s) ago
Navin Kapur, professor of medicine, has been honored with the 2024 Zucker Family Prize. This prize is awarded annually to a TUSM faculty member for a career of outstanding research and is given in recognition of Kapur’s exceptional achievements spanning basic, translational, and clinical sciences. Karen Freund, the Sheldon M. Wolff Professor and chair of medicine at TUSM, nominated Navin for the prize, stating, “It is an honor to support the nomination of Dr. Navin Kapur for the Zucker Family Prize
Source: medicine.tufts.eduCategories: General Medicine News, CardiologistsTweet-
Congratulations to my mentor @NavinKapur4 for Zucker Family Prize for Outstanding Research @TuftsMedicalCtr #CSWG @BurkhoffMd @manreetkanwar @JHMontfort10 @ReshadGaranMD @Abraham_Jacob 🐐 🐐 🐐 https://t.co/nUp3jY0RDU
-
RT @AJBloodMD: https://t.co/MmlUlRiv0v Excited to share my recent interview with @JAMA_current , discussing #AI in clinical trials. These…